+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer

Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer

Oncology Reports 39(3): 1338-1346

Early detection of gastric cancer (GC) is crucial to improve the therapeutic effect and prolong the survival of patients. MicroRNAs (miRNAs) are a group of small non-protein-coding RNAs that function as repressors of diverse genes. We aimed to identify a microRNA panel in the serum of patients to predict GC non-invasively with high accuracy and sensitivity. Using six types of classifiers, we selected three markers (miR‑21-5p, miR-22-3p and miR-29c-3p) from a published miRNA profiling study (GSE23739) which was treated as a training set. The values of the area under the receiver operating characteristic (ROC) curves (AUCs) were 0.9437, 0.9456 and 0.9563 in the three classifiers [Compound covariate classifier, Diagonal linear discriminant analysis (DLDA) classifier and Support vector machine classifier], respectively. Then the panel was validated further in another two miRNA profiles in GEO (Gene Expression Omnibus) databases (GSE26595, GSE28700) with high AUC values as well. Next, we found that the serum levels of miR-21 were significantly higher in GC patients than levels in healthy controls by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for confirmation, which was opposite to the serum levels of miR-22 and miR-29c (all P<0.0001). Finally, using bioinformatic tools, their biological mechanisms were elucidated by their predicted targets: Sp1 (miR-21) and PTEN (miR-22 and miR-29c). This miRNA panel is a non‑invasive and potential biomarker for GC.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 065507006

Download citation: RISBibTeXText

PMID: 29286167

DOI: 10.3892/or.2017.6163

Related references

A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Biochemical and Biophysical Research Communications 493(3): 1322-1328, 2017

Identification and Validation of Serum MicroRna Biomarker for Early Detection of Gastric Cancer. Gastroenterology 146(5): S-31, 2014

Unsaturated free fatty acids: a potential biomarker panel for early detection of gastric cancer. Biomarkers 19(8): 667-673, 2015

Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Letters 316(2): 196-203, 2012

Serum Unsaturated Free Fatty Acids: A Potential Biomarker Panel for Early-Stage Detection of Colorectal Cancer. Journal of Cancer 7(4): 477-483, 2016

A microRNA biomarker panel for the non-invasive detection of bladder cancer. Oncotarget 7(52): 86290-86299, 2016

Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. European Urology 63(6): 1091-1100, 2013

Circulating microRNA-133, microRNA-17 and microRNA-25 in serum and its potential diagnostic value in gastric cancer. Journal of Cellular Biochemistry 2019, 2019

MicroRNA-873 is a Potential Serum Biomarker for the Detection of Ectopic Pregnancy. Cellular Physiology and Biochemistry 41(6): 2513-2522, 2017

Circulating MicroRNA-21 Is a Potential Diagnostic Biomarker in Gastric Cancer. Disease Markers 2015: 435656, 2016

A two-microRNA signature as a potential biomarker for early gastric cancer. Oncology Letters 7(3): 679-684, 2014

Serum microRNA expression profile as a diagnostic panel for gastric cancer. Japanese Journal of Clinical Oncology 46(9): 811-818, 2017

Serum microRNA-218 is a potential biomarker for esophageal cancer. Cancer Biomarkers 15(4): 381-389, 2016

A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer. Annals of Surgical Treatment and Research 92(2): 55-66, 2017

MicroRNA-410-5p as a potential serum biomarker for the diagnosis of prostate cancer. Cancer Cell International 16: 12, 2016